Log in

OTCMKTS:SNYNFRoche Stock Price, Forecast & News

$95.35
+1.36 (+1.45 %)
(As of 05/27/2020 04:00 PM ET)
Add
Compare
Today's Range
$93.69
Now: $95.35
$95.35
50-Day Range
$87.00
MA: $95.96
$103.00
52-Week Range
$77.00
Now: $95.35
$104.30
Volume615 shs
Average Volume8,253 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Sanofi provides therapeutic solutions worldwide. It offers Cerezyme and Cerdelga for Gaucher, Myozyme and Lumizyme for Pompe, Fabrazyme for Fabry, and Aldurazyme for mucopolysaccharidosis Type 1; and Aubagio, an immunomodulatory and Lemtrada, a monoclonal antibody for multiple sclerosis. It also provides Dupixent for atopic dermatitis; Kevzara for rheumatoid arthritis; Eloctate and Alprolix to treat hemophilia; and Cablivi to treat acquired thrombotic thrombocytopenic purpura. In addition, it offers Libtayo for metastatic cutaneous squamous cell carcinoma; Jevtana and Taxotere taxane for cancers; Eloxatin for colon cancer; Thymoglobulin, an immunosuppressive and immunomodulating agent; Mozobil, for hematologic malignancies; and Zaltrap, for metastatic colorectal cancer. Further, it provides Lantus, Toujeo, Apidra, and Insuman insulins; Amaryl sulfonylurea; Adlyxin/Lyxumia, a GLP-1 receptor agonist; Soliqua 100/33/Suliqua, an insulin glargine and lixisenatide combination to treat diabetes; Admelog/Insulin lispro insulin; Praluent, a cholesterol-lowering drug; and Multaq, an anti-arrhythmic drug for atrial fibrillation. Additionally, it offers Plavix for atherothrombotic conditions; Lovenox for the prophylaxis, venous thromboembolism, and acute coronary syndrome; Aprovel and CoAprovel anti-hypertensives; Renagel and Renvela for patients undergoing dialysis; Synvisc and Synvisc-One viscosupplements for osteoarthritis; Stilnox for insomnia; Allegra for seasonal allergic rhinitis and uncomplicated hives; and Depakine for epilepsy. It also provides generic products; and products for allergy, cough, cold, pain, nutrition, digestion, pediatrics, influenza, meningitis, travel, and endemic vaccines; and adult and adolescent boosters. Sanofi has an alliance with Verily Life Sciences LLC; and agreement with Happify Health. Sanofi was formerly known as Sanofi-Aventis and changed its name to Sanofi in May 2011. Sanofi was founded in 1973 and is headquartered in Paris, France.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 4.1Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.82 out of 5 stars


Industry, Sector and Symbol

Industry Drug Manufacturers - Major
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:SNYNF
CUSIPN/A
CIKN/A
Phone33 1 53 77 40 00

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Employees104,226
Next Earnings DateN/A
OptionableNot Optionable

Receive SNYNF News and Ratings via Email

Sign-up to receive the latest news and ratings for SNYNF and its competitors with MarketBeat's FREE daily newsletter.

Roche (OTCMKTS:SNYNF) Frequently Asked Questions

How has Roche's stock been impacted by COVID-19 (Coronavirus)?

Roche's stock was trading at $88.9910 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, SNYNF stock has increased by 7.1% and is now trading at $95.35. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Roche?

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Roche in the last year. There are currently 5 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Roche.

Has Roche been receiving favorable news coverage?

News stories about SNYNF stock have trended somewhat positive this week, according to InfoTrie Sentiment Analysis. The research group rates the sentiment of press coverage by reviewing more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Roche earned a daily sentiment score of 1.6 on InfoTrie's scale. They also gave media stories about the company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an impact on the stock's share price in the near term. View the latest news aboutRoche.

Who are some of Roche's key competitors?

Who are Roche's key executives?

Roche's management team includes the following people:
  • Mr. Paul Hudson, Chief Exec. Officer (Age 52)
  • Mr. Jean-Baptiste Chasseloup de Chatillon, Exec. VP & CFO (Age 54)
  • Mr. Laurent Gilhodes, Principal Accounting Officer and VP of Corp. Accounting
  • Mr. Bruno Ménard, Chief Information officer
  • Mr. George Grofik, Head of Investor Relations

What is Roche's stock symbol?

Roche trades on the OTCMKTS under the ticker symbol "SNYNF."

How do I buy shares of Roche?

Shares of SNYNF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Roche's stock price today?

One share of SNYNF stock can currently be purchased for approximately $95.35.

What is Roche's official website?

The official website for Roche is www.sanofi.com.

How can I contact Roche?

The company can be reached via phone at 33 1 53 77 40 00.

This page was last updated on 5/28/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.